Track the 乐普医疗 share price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 乐普医疗 has logged 2 public disclosures. Market capitalisation: €24.1bn. The latest transaction was reported on 24 August 2026 (Purchase). Among the most active insiders: 蒲忠杰. Every trade is accessible without an account.
Analysts rate 乐普医疗 Strong Buy (bullish), based on 4 analysts. Average price target: CN¥19.39.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
乐普医疗 es una empresa especializada en el sector de la salud y farmacéutico, que ofrece soluciones innovadoras para el diagnóstico y tratamiento médico. Cotiza en el mercado XSHE.